Associate Director, Regulatory CMC Compliance

Overview

The Associate Director, Regulatory Compliance will help develop and drive department-wide global regulatory compliance strategies, with input from key program, Regulatory, Quality and CMC stakeholders. These strategies will be designed to ensure Alnylam’s program(s) meet global health authority requirements and remain compliant throughout the lifecycle of the product. This role will oversee core capabilities and strategic innovation activities of the RA CMC team. This role is a critical position to ensure successful global clinical development, registration, and product life cycle management in a streamlined, efficient, and compliant manner.

Summary Of Key Responsibilities

• Leads and manages Compliance activities on behalf of the RA CMC organization and serve as the point of contact for Regulatory CMC on audits & inspections.
• Support development and management of a program for tracking, execution, monitoring, and reporting on RA CMC processes (Metrics and KPIs) to drive excellence in Regulatory CMC pre- and post-submission activities.
• Utilizes technical knowledge, regulatory expertise and global regulatory lessons learned to shape global regulatory best practices, drive internal consistency and influence effective change management.
• Collaborates across RA CMC to ensure clear and timely communication about compliance risks, business processes, compliance activities and metrics arising on programs.
• Work cross-functionally with Regulatory, Quality, and CMC to support global strategic initiatives related to pre and post submission activities and the processes and systems used to manage compliance.
• Serve as RA CMC point of contact for Compliance and QMS operational activities
• Maintain knowledge of the global regulatory environment, regulations, and guidelines and participate in regulatory intelligence activities to help ensure Alnylam dossiers remain in compliance with shifting expectations.
• Escalate issues/problems to RA CMC LT as needed and propose risk-based remediation actions for consideration.
• Working with other RA CMC functions, ensure RA CMC Commitments (i.e. IND, post marketing) and Quality Events are managed within specified timelines.
• Identify opportunities to improve RA CMC compliance capabilities through digital solutions and automation
• Actively participate in RA CMC process improvement and capability building.
  
  

Qualifications

• BS in science related field required. Advanced degree (eg MS, PhD) preferred.
• 8 years of experience in the pharmaceutical/biotechnology/life science industry, with direct hands-on experience in relevant fields, such as Product Quality, Quality Systems, CMC Technical Writing or Regulatory Affairs, CMC.
• Nuanced understanding of regulatory risk and ability to develop risk mitigation strategies
• Experience in technical systems and mining data for trends, resulting in meaningful and reportable metrics.
• Experience managing and/or preparing submissions, with the ability to optimize/streamline processes.
• Solid understanding of scientific principles and regulatory requirements relevant to global product development, registration and post-market support
• Experience in managing complex CMC changes (eg process, facility, formulation.
• Knowledge and understanding of US, EU, Canada, and ICH guidelines pertinent to CMC. Understanding of international requirements is a plus.
• Strong interpersonal skills; ability to influence key stakeholders
• Excellent written and communication skills and attention to detail.
• Demonstrated strong organizational skills including ability to prioritize tasks and adhere to agreed timelines.
• Highly computer literate (eg, Word, Excel, PowerPoint), Experience using Smartsheets, Veeva and Docubridge desirable
  
  

About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law.